Chemical Sphicterotomy versus Surgical Sphicterotomy in the Management of Chronic Fissure in ANO: A Prospective, Randomized TrialCorrespondence Address :
Dr. Rithin Suvarna
AJIMS, Mangalore, India.
Introduction: Fissure in ano is a common cause of severe anal pain. The hypertonia and spasm of the internal anal sphincter is believed to be the chief pathology in chronic fissures. The reduction of this hypertonia is most commonly achieved by surgical sphincterotomy, that results in fissure healing in more than 90% of the cases. However, the surgery carries a significant risk of incontinence. In this study, we explored chemical sphincterotomy by using topical 2% diltiazem as an effective and a safe alternative method to the surgical treatment for chronic fissure in ano.
Materials and Methods:
In this prospective trial, 200 patients with chronic anal fissures were randomly divided into group 1 and group 2, with 100 patients in each group. The group 1 cases received 2% topical diltiazem at the perianal skin twice daily for 6 weeks, while the group 2 subjects underwent lateral internal sphincterotomy. They were assessed biweekly during the treatment. The follow up was carried out for one year.
Complete fissure healing was found in 69.23% patients of group 1 (topical diltiazem) and in 95.87% patients of group 2 (surgical sphincterotomy). In the first group, the pain relief was fairly good, while in group 2, the response was quick and excellent. Mild headache was the main side effect in group1, while it was anal incontinence in group 2. 10.43% of the cases from the group 1 had recurrence, whereas none in the second group had it.
We conclude that chemical sphincterotomy with the use of 2% topical diltiazem may be considered as first line treatment for chronic anal fissure. Surgical sphincterotomy should be reserved for patients who have failed to respond to chemical sphincterotomy.
Fissure-in-ano, Sphincterotomy, Topical diltiazem
Rithin Suvarna, Panchami, Guruprasad Rai D.. CHEMICAL SPHICTEROTOMY VERSUS SURGICAL
SPHICTEROTOMY IN THE MANAGEMENT OF
CHRONIC FISSURE IN ANO: A PROSPECTIVE,
RANDOMIZED TRIAL. Journal of Clinical and Diagnostic Research [serial online] 2012 August [cited: 2019 Oct 20 ]; 6:1018-1021. Available from
Fissure in ano (AF) is a common proctologic condition in which there is a linear laceration in the lining of the distal anal canal, which is a common cause of severe anal pain (1). The pathogenesis of anal fissures is not well understood (2). Constipation and hard stools have been thought to be the important initiating factors (3). The chief pathology in chronic fissures appears to be persistent hypertonia and spasm of the internal anal sphincter (4),(5),(6). The reduction of this hypertonia improves the local blood supply and encourages the fissure healing. Chronic anal fissures, unlike acute fissures, don’t usually resolve with simple measures (7). They are most commonly treated by surgical sphincterotomy that heals the fissures in more than 90% of the cases (7),(8). However, the surgery carries a significant risk of incontinence (9)(10),(11). This limitation of the surgery has led to a search for alternative therapies such as topical diltiazem (chemical sphincterotomy), topical glyceryl trinitrate, etc. The aim of this prospective randomized trial was to compare the effectiveness and the side effects of chemical sphincterotomy (with the use of topical 2% diltiazem) versus surgical sphincterotomy in the treatment of chronic anal fissures.
This prospective, comparative study was undertaken at the Vinaya Hospital and Research Centre, South Canara, from 2009 to 2012. Two hundred patients with a definite diagnosis of chronic anal fissure were enrolled in this study after obtaining an informed written consent from them. Ethical approval was obtained from the local ethical committee. The inclusion criteria included the patients who were aged between The first group was treated with a 2% diltiazem ointment (chemical sphincterotomy). The subjects were instructed to apply the ointment (about a size of a pea) to the anal margin by using their tip of the index finger, twice daily for 6 consecutive weeks. The cases from the second group underwent left lateral internal sphincterotomy under spinal/general anaesthesia. During the course of the treatment, both the groups were asked to eat a high fibre diet and to use warm sitz baths. They were reviewed in the Outpatients Department at the 2nd, 4th and 6th weekends during the course of the treatment and then, bimonthly for a year. At each visit, details on the fissure healing, pain relief and any side effects and recurrence were noted down. Also, specific questions were asked, particularly to the second group, regarding the leakage of flatus and faeces. The healing of the fissure was assessed visually and the intensity of the pain was assessed from a visual analogue score. Healing was defined as the complete disappearance of the fissure on examination. Every patient was supplied with a pain score chart. There were instructed to mark the level of the pain in it daily. These charts were graded from 0 to 10 and they were marked at one end- 0 (no pain) and at the other end -10 (worst pain). The disease was considered as recurrent if the fissure reappeared at the same site, 2 months after the surgery or 2 months after the 6 weeks course of the diltiazem application. The data was collected and analyzed statistically by using the SPSS version17 software. The p values were calculated by using the Chi-square test.
The clinical details of the 200 cases which were studied have been shown in the (Table/Fig 1).In the first group, there was a slight female predominance, whereas a slight male predominance was observed in second group (Table/Fig 1). A majority of the cases in both the groups had anal pain and bleeding. A few cases had constipation as well. Diabetes mellitus and hypertension were noted in few patients. The commonest location was the posterior midline (Table/Fig 1). Most of the cases had sphincter spasms and an external skin tag (sentinel pile). The cases were evaluated at the 2nd, 4th and 6th weekends for fissure healing, pain alleviation, side effects and recurrences. 9 cases from group 1 and 3 cases from group 2 failed to complete the study due to cooperation problems. These subjects were not considered in the statistical analysis.Complete fissure healing was noted in 69.23% patients of group 1 (chemical sphincterotomy) and in 95.87% patients of group 2 (surgical sphincterotomy) within 6 weeks (Table/Fig 2).In the first group, the pain response was fairly good. The pain score (mean) fell steadily over 6 weeks (Table/Fig 3). But the pain alleviation in the second group was excellent and quick. In the second group, a steep drop in the pain score was noted in the first two weeks (Table/Fig 3).Mild headache was experienced by 5.49% patients of group 1, while none of the patients in group 2 had it. 9.27% of the cases from group 2 complained of flatus incontinence, whereas none of the cases in group 1 had it. However, the flatus incontinence improved over time, so that at the end of the 1year follow up, only 2 cases still had it. 5.15% cases in group 2 had a frank faecal incontinence in the first 6 weeks. Nevertheless, it also resolved completely over time (Table/Fig 4).5 of the 63 fissure healers from group 1 and 4 of the 93 healers from group 2 didn’t show up for follow up, while the rest of the patients completed the full 1 year’s follow up.10.43% of the cases from group 1 had recurrence, while none in group 2 had it (Table/Fig 5).
Fissure in ano is a common proctologic disease in which there is a vertical tear in the lining of the distal anal canal (1). The posterior midline is the commonest location, followed by the anterior midline, especially in females (12). The pathogenesis of chronic AFs is poorly understood (2) (Table/Fig 6). Constipation and hard stools are often associated with fissures and they have been believed to initiate fissure formation (3). Inflammatory bowel disease and tuberculosis may be associated with fissures. In females, they often occur during pregnancy and following delivery (7). Chronic AFs are associated with internal anal sphincter hypertonia. The reduction of this hypertonia improves the local blood supply, thus encouraging the fissure healing. A sharp anal pain during defaecation, which is associated with the passage of bright red blood per rectum, is the classical feature of AFs (1) . The pain may be so severe, especially in acute fissures, that the patients may postpone the defaecation for days together until it becomes inevitable (7).This leads to hardening of the stools, which further worsens the condition. The fissures can be acute or chronic. Acute fissures have a shorter duration (less than a month) and they have fresh mucosal edges (1). They usually resolve with the use of simple measures like a high fibre diet, adequate water intake, and warm sitz baths (1). Chronic fissures are characterized by a sentinel pile, hypertophic anal papillae, anal spasms and/or fibrosis of the internal sphincter muscle (2). The internal sphincter fibres are usually exposed on the floor of the well developed fissure which goes into spasm due to irritation (7). The chronic AFs usually do not heal with simple conservative measures (7). They are most commonly treated surgically by lateral internal anal sphincterotomy, which lowers the resting anal pressure and heals them in more than 90% of the cases (7),(8). But, sphincterotomy carries a significant risk of incontinence (8),(9),(10)(11). This drawback of the surgical treatment has led to a search for alternative therapies. Chemical sphincterotomy has been tried by using a variety of agents which include topical glyceryl trinitrate (GTN), calcium channel blockers such as nifedipine or diltiazem and botulinum toxin. Some of these agents were found to be effective in healing chronic anal fissures with negligible side effects and these are now being considered as the first line treatment for chronic AFs (13). However, the medical treatment has two limitations: the moderate effectiveness (between 30% and 80%) and the need for a prolonged treatment (10). Topical GTN has been the most extensively studied and followed non-surgical treatment for chronic anal fissures (8). Although it is effective, headache and a high recurrence rate are its main drawbacks (1), (14),(15),(16),(17),(18). Diltiazem is a calcium channel blocker which acts by blocking the calcium channels in the smooth muscles, thus causing relaxation (1). Various studies have reported a 60% to 75% fissure healing rate with topical diltiazem (19),(20),(21),(22). Moreover, topical diltiazem causes less headache and a fewer side effects than the GTN ointment (19), (23).
We conclude that chemical sphincterotomy with the use of topical 2% diltiazem may be considered as the first line treatment for chronic anal fissures, in spite of the higher rate of recurrence and the temporary anal incontinence. Lateral internal sphincterotomy should be reserved for the patients who have failed to respond to the initial chemical sphincterotomy.
We would like to thank all the consultant surgeons at the Vinaya Hospital and Research Centre, south Canara, for allowing us to analyze their cases. We are very grateful to Dr Nanjesh and Dr Tantry for their help with the statistical analysis. The authors confirm that there are no known conflicts of interest which are associated with this publication and that there has been no financial support for this work that could have influenced its outcome.
INANCIAL OR OTHER COMPETING INTERESTS:
Date of Submission: Apr 09, 201 2
Date of Peer Review: May 09, 20 12
Date of Acceptance: Jun, 2012
Date of Online Ahead of Print: Jul 02, 2012
- Emerging Sources Citation Index (Web of Science, thomsonreuters)
- Index Copernicus ICV 2017: 134.54
- Academic Search Complete Database
- Directory of Open Access Journals (DOAJ)
- Google Scholar
- HINARI Access to Research in Health Programme
- Indian Science Abstracts (ISA)
- Journal seek Database
- Popline (reproductive health literature)